GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Payments to Suppliers for Goods and Services

Beximco Pharmaceuticals (DHA:BXPHARMA) Payments to Suppliers for Goods and Services : BDT-30,944 Mil (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Payments to Suppliers for Goods and Services?

Beximco Pharmaceuticals's Payments to Suppliers for Goods and Services for the three months ended in Dec. 2023 was BDT0 Mil.

Beximco Pharmaceuticals's Payments to Suppliers for Goods and Services for the trailing twelve months (TTM) ended in Dec. 2023 was BDT-30,944 Mil.


Beximco Pharmaceuticals Payments to Suppliers for Goods and Services Historical Data

The historical data trend for Beximco Pharmaceuticals's Payments to Suppliers for Goods and Services can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Payments to Suppliers for Goods and Services Chart

Beximco Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Payments to Suppliers for Goods and Services
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17,434.69 -18,467.46 -22,500.77 -28,565.27 -30,943.67

Beximco Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Payments to Suppliers for Goods and Services Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8,584.42 -7,817.54 -7,286.49 -7,255.22 -

Beximco Pharmaceuticals Payments to Suppliers for Goods and Services Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Payments to Suppliers for Goods and Services represents cash paid to suppliers when purchasing goods or services by the company in the direct cash flow method.

Payments to Suppliers for Goods and Services for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-30,944 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Industry
Traded in Other Exchanges
Address
19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines